LncRNA ucoo2kmd.1调控肾结石病中粘附因子CD44的机制研究
批准号:
81970601
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
王博涵
依托单位:
学科分类:
泌尿系结石与感染
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
王博涵
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
尿石症是泌尿外科最常见的疾病之一,但是其发病机制目前仍不明确。经典的结石形成理论包括:尿液中晶体过饱和、晶体成核、晶体生长、晶体的聚集以及结晶的粘附,其中结晶的粘附是重要的致病因素。本课题组前期通过基因芯片筛选出lncRNA UCOO2KMD.1有促进晶体粘附的作用。根据生物信息学分析,我们发现UCOO2KMD.1与CD44有一段相同的碱基序列,且这段序列与miR-211-3p互补。研究表明,CD44和p38丝裂原活化蛋白激酶途径(MAPK)在晶体粘附过程中有重要的作用。由此,我们推测,UCOO2KMD.1通过竞争miR-211-3p参与CD44的调控,并参与激活p38 MAPK信号通路,从而影响晶体的粘附,最终导致结石形成。本项目拟通过研究UCOO2KMD.1、miR-211-3p、CD44和p38 MAPK信号通路在尿石形成中的作用及机制,为进一步阐明尿石症的发病机制提供依据。
英文摘要
Urolithiasis is one of the most common urological diseases; however, the pathogenesis is still unclear. Classical stone formation theories include: supersaturation of crystals in urine, nucleation of crystals, growth of crystals, aggregation of crystals and adhesion of crystals. Adhesion of crystals is an important pathogenic factor. In our previous study, lncRNA ucoo2kmd.1 was screened out to have the effect of promoting cell crystal adhesion through gene chip technology. According to the analysis of biological software, we found that ucoo2kmd.1 and CD44 have the same base sequence, and this base sequence is complementary to mir-211-3p. Previous studies have shown that CD44 and p38 mitogen-activated protein kinase (MAPK) pathways play an important role in cell adhesion. Therefore, we speculated that ucoo2kmd.1 participated in the regulation of CD44 by competing with mir-211-3p and regulating the p38 MAPK signaling pathway, thereby affecting the adhesion of crystals and ultimately leading to the formation of stones. This project aims to study the role and molecular mechanism of ucoo2kmd.1, mir-211-3p, CD44 and p38 MAPK signaling pathway in the process of renal stone formation, so as to further clarify the initial process of renal stone formation.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1155/2022/4345037
发表时间:2022
期刊:Oxidative medicine and cellular longevity
影响因子:--
作者:Wang B;Wei J;Huangfu Q;Gao F;Qin L;Zhong J;Wen J;Ye Z;Yang X;Liu H
通讯作者:Liu H
DOI:10.21037/tau-21-1138
发表时间:2022-03
期刊:Translational andrology and urology
影响因子:2
作者:Wei J;Zhang S;Wang B;Ke M;Liu S;Yang Z;Zhou G;Qian J;Lv W;Fan Y;Shi Z;Wan L;Chen Y;He J;Liang H;Long H;Wang S;Wang H;Chen B;Shao H;Yang B;Sun C;Huangfu Q;Du C;Cai M;Wen J
通讯作者:Wen J
Comparison between a transurethral prostate split and transurethral prostate resection for benign prostatic hyperplasia treatment in a small prostate volume: a prospective controlled study
经尿道前列腺劈开术与经尿道前列腺切除术治疗小前列腺良性前列腺增生的比较:一项前瞻性对照研究。
DOI:10.21037/atm-20-5462
发表时间:2020-08-01
期刊:ANNALS OF TRANSLATIONAL MEDICINE
影响因子:--
作者:Wang, Bohan;Zhang, Shigeng;Wen, Jiaming
通讯作者:Wen, Jiaming
DOI:10.1007/s11255-023-03611-3
发表时间:2023
期刊:International Urology and Nephrology
影响因子:--
作者:Zhiyue Wu;Jingchao Wei;Chengfang Sun;Qi Huangfu;Bohan Wang;Guangyi Huang;Kai Qi;Zeping Jiang;Wuan Zhu;Jiaming Wen
通讯作者:Jiaming Wen
Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma.
单细胞多组学分析揭示透明细胞肾细胞癌的调控程序
DOI:10.1038/s41421-022-00415-0
发表时间:2022-07-19
期刊:Cell discovery
影响因子:33.5
作者:Long Z;Sun C;Tang M;Wang Y;Ma J;Yu J;Wei J;Ma J;Wang B;Xie Q;Wen J
通讯作者:Wen J
Protectin D1通过调控铜死亡介导的炎症通路抑制泌尿系结石形成的机制研究
- 批准号:82370762
- 项目类别:面上项目
- 资助金额:49万元
- 批准年份:2023
- 负责人:王博涵
- 依托单位:
miR-10b通过调节CD44影响肾小管细胞粘附能力在泌尿系结石中的应用
- 批准号:81500532
- 项目类别:青年科学基金项目
- 资助金额:18.0万元
- 批准年份:2015
- 负责人:王博涵
- 依托单位:
国内基金
海外基金















{{item.name}}会员


